State of Tennessee Department of Treasury trimmed its position in shares of DaVita Inc. (NYSE:DVA - Free Report) by 18.9% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 26,742 shares of the company's stock after selling 6,235 shares during the period. State of Tennessee Department of Treasury's holdings in DaVita were worth $3,999,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Epoch Investment Partners Inc. acquired a new position in shares of DaVita during the fourth quarter worth approximately $55,100,000. Invesco Ltd. raised its stake in DaVita by 20.9% during the 4th quarter. Invesco Ltd. now owns 1,589,545 shares of the company's stock valued at $237,716,000 after acquiring an additional 275,284 shares in the last quarter. Amundi grew its stake in shares of DaVita by 116.4% in the fourth quarter. Amundi now owns 446,386 shares of the company's stock worth $68,726,000 after purchasing an additional 240,126 shares in the last quarter. Bridgewater Associates LP increased its holdings in shares of DaVita by 298.4% during the fourth quarter. Bridgewater Associates LP now owns 239,970 shares of the company's stock valued at $35,888,000 after purchasing an additional 179,744 shares during the period. Finally, Skandinaviska Enskilda Banken AB publ raised its stake in shares of DaVita by 256.8% during the fourth quarter. Skandinaviska Enskilda Banken AB publ now owns 162,233 shares of the company's stock valued at $24,301,000 after purchasing an additional 116,758 shares in the last quarter. Institutional investors own 90.12% of the company's stock.
DaVita Trading Up 0.0 %
NYSE:DVA opened at $139.57 on Friday. The stock has a fifty day simple moving average of $146.50 and a 200 day simple moving average of $155.30. The firm has a market capitalization of $11.17 billion, a price-to-earnings ratio of 13.00, a price-to-earnings-growth ratio of 1.07 and a beta of 1.04. DaVita Inc. has a 1-year low of $130.96 and a 1-year high of $179.60. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18.
DaVita (NYSE:DVA - Get Free Report) last announced its earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. Sell-side analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current year.
Wall Street Analysts Forecast Growth
Several equities analysts have commented on the stock. Cowen reissued a "hold" rating on shares of DaVita in a research note on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 price objective on shares of DaVita in a research note on Friday, February 21st. StockNews.com raised DaVita from a "hold" rating to a "buy" rating in a research note on Friday. Finally, Barclays boosted their price objective on DaVita from $164.00 to $169.00 and gave the stock an "equal weight" rating in a research note on Tuesday, February 18th. One research analyst has rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, DaVita presently has a consensus rating of "Hold" and an average target price of $166.33.
Check Out Our Latest Research Report on DVA
DaVita Company Profile
(
Free Report)
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Recommended Stories
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider DaVita, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DaVita wasn't on the list.
While DaVita currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.